Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Rezende, V
Long-term use is not recommended without guidance
Can IV and Oral Be Combined Together
Completed Phase II and III clinical trials have indicated that the agent has a nonoverlapping toxicity profile and synergistic effects with carboplatin, paclitaxel, and anthracycline, has no cross-drug resistance and is well tolerated, with patients mostly reporting fatigue and nausea
In the field of research and development of multi-target receptor agonist drugs, there are currently several multi-receptor agonists under research in the world that have entered the clinical stage
US$ 20.46
US$ 24.18
US$ 28.02
US$ 28.74
US$ 23.62
